Providing novel possibilities for all life.

In infertility treatment, the function of eggs and sperm declines with age, reducing the likelihood of pregnancy and successful delivery.
We address this challenge by leveraging world-class germ cell technology to deliver innovative solutions for everyone who dreams of having a child.

PLATFORM

We use our proprietary differentiation induction technology to efficiently induce oocytes and ovarian somatic cells from iPS cells.
We aim to create state-of-the-art solutions to a myriad of problems surrounding pregnancy.

 

Grow with Us

We’re looking for high-performing individuals who are passionate about science and excited to work in a collaborative environment fueled by a rigorous or entrepreneurial culture.

Grow with Us

INVESTORS

  • anri
  • CORAL
  • Spiral Capital
  • Archetype Ventures
  • DG Daiwa Ventures
  • フューチャーベンチャーキャピタル
  • あすか製薬株式会社
  • 株式会社Carbon Ventures

FEATURED IN

  • nature
  • TC
  • BRIDGE
  • 日経バイオテク
  • Forbes japan

ACCESS

U.S. Office

214 Homer Ave, Palo Alto, CA 94301

Headquarters

1-17-8 Shinkiba, Koto-ku, Tokyo 136-0082, Japan Mitsui Link Lab Shinkiba 2 Room 223

Kumamoto Laboratory

2-2-1, Honjo, Chuo-ku, Kumamoto-shi, Kumamoto Kumamoto University, 860-8556

ページトップへ